Taysha Gene Therapies, Inc.
TSHA
9 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Apr 13 8:33 PM | Sukumar NagendranDirector, President and Head of R&D | Sale | 200,000 | $4.46 | $892.0K | 1,136,410(D) | View → |
| Apr 10, 2026 | Apr 10 8:11 PM | Nagendran Sukumar | Proposed Sale | 200,000 | $4.63 | $926.0K | — | View → |
| Feb 27, 2026 | Feb 27 9:07 PM | Rumana Haque-Ahmed | Proposed Sale | 2,405 | $4.57 | $11.0K | — | View → |
| Feb 4, 2026 | Feb 6 9:30 PM | Kamran AlamCHIEF FINANCIAL OFFICER | Sale | 1,655 | $4.52 | $7.5K | 1,442,131(D) | View → |
| Feb 4, 2026 | Feb 4 11:44 PM | Emily McGinnis | Proposed Sale | 901 | $4.72 | $4.3K | — | View → |
| Feb 4, 2026 | Feb 4 11:42 PM | Fred Porter | Proposed Sale | 889 | $4.72 | $4.2K | — | View → |
| Feb 4, 2026 | Feb 4 11:41 PM | Sean McAuliffe | Proposed Sale | 914 | $4.72 | $4.3K | — | View → |
| Feb 4, 2026 | Feb 4 11:39 PM | Rumana Haque-Ahmed | Proposed Sale | 697 | $4.72 | $3.3K | — | View → |
| Feb 4, 2026 | Feb 4 11:38 PM | Kamran Alam | Proposed Sale | 1,655 | $4.72 | $7.8K | — | View → |
| Jan 26, 2026 | Jan 27 9:05 PM | Sukumar NagendranDirector, President and Head of R&D | Sale | 26,918 | $4.61 | $124.1K | 1,317,389(D) | View → |
| Jan 23, 2026 | Jan 27 9:05 PM | Sukumar NagendranDirector, President and Head of R&D | Sale | 89,132 | $4.75 | $423.4K | 1,344,307(D) | View → |
| Jan 26, 2026 | Jan 27 9:05 PM | Sean P. NolanDirector, Chief Executive Officer | Sale | 41,312 | $4.61 | $190.4K | 2,908,257(D) | View → |
| Jan 23, 2026 | Jan 27 9:05 PM | Sean P. NolanDirector, Chief Executive Officer | Sale | 136,789 | $4.75 | $649.7K | 2,949,569(D) | View → |
| Jan 26, 2026 | Jan 27 9:05 PM | Kamran AlamCHIEF FINANCIAL OFFICER | Sale | 23,849 | $4.61 | $109.9K | 1,443,786(D) | View → |
| Jan 23, 2026 | Jan 27 9:05 PM | Kamran AlamCHIEF FINANCIAL OFFICER | Sale | 78,968 | $4.75 | $375.1K | 1,467,635(D) | View → |
| Jan 23, 2026 | Jan 24 1:07 AM | Sean P. Nolan | Proposed Sale | 168,078 | $5.09 | $855.5K | — | View → |
| Jan 23, 2026 | Jan 24 1:05 AM | Sukumar Nagendran | Proposed Sale | 113,824 | $5.09 | $579.4K | — | View → |
| Jan 23, 2026 | Jan 24 1:04 AM | Rumana Haque-Ahmed | Proposed Sale | 30,052 | $5.09 | $153.0K | — | View → |
| Jan 23, 2026 | Jan 24 1:02 AM | Fred Porter | Proposed Sale | 54,916 | $5.09 | $279.5K | — | View → |
| Jan 23, 2026 | Jan 24 1:01 AM | Emily McGinnis | Proposed Sale | 32,077 | $5.09 | $163.3K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2 8:30 PM | John A Stalfort IIIDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Phillip B. DonenbergDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Alison S LongDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Laura Sepp-LorenzinoDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Apr 10, 2026 | Apr 13 8:33 PM | Sukumar NagendranDirector, President and Head of R&D | Option Exercise | 19,021 | $1.71 | 455,920(D) | View → |